Recce Pharmaceuticals Ltd (RCE) — Cash Flow Reinvestment Rate

Latest as of June 2026: 0.10x

Recce Pharmaceuticals Ltd (RCE) has a Cash Flow Reinvestment Rate of 0.10x as of June 2026, reinvesting AU$34.98K (capex AU$34.98K ) from operating cash flow of AU$341.10K. See Recce Pharmaceuticals Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.10x
(Capex + Investments) / Operating CF

Total Reinvested

AU$34.98K
Capex + Investments

Operating Cash Flow

AU$341.10K
AUD

Capital Expenditures

AU$34.98K
AUD

Recce Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2014–2014)

Historical reinvestment intensity for Recce Pharmaceuticals Ltd across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Recce Pharmaceuticals Ltd.

Annual Cash Flow Reinvestment Rate for Recce Pharmaceuticals Ltd (2014–2014)

Year-by-year capital reinvestment analysis for Recce Pharmaceuticals Ltd. See how financially flexible is Recce Pharmaceuticals Ltd to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2014 3.08x AU$35.25K AU$11.43K AU$35.25K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow